Clear

Clear.bio is a Dutch health-tech company focused on helping people with type 2 diabetes improve their health through personalized nutrition, real-time glucose monitoring, and digital coaching. Its approach is built around the idea that people respond differently to food, so better outcomes come from understanding each person’s own biological response rather than following a one-size-fits-all diet. The company serves people with type 2 diabetes and, in some materials, people with prediabetes or excess weight. It positions itself as a practical, science-based alternative that makes better health simpler and more accessible by combining a glucose sensor, app-based guidance, and access to dietitians. Clear.bio also presents itself as a digital care partner for healthcare professionals and organizations. Its platform is designed to support personalized advice, improve self-management, and make lifestyle-based diabetes care more scalable. Core Values Personalization : Clear.bio emphasizes that every body responds differently to food, so advice should be based on individual glucose data and personal context. Science-based care : The company repeatedly grounds its approach in nutritional science, clinical research, and collaboration with medical and scientific advisors. Accessibility : Clear.bio aims to make better health and diabetes support easier to access through digital tools, remote coaching, and scalable care. Empowerment : The platform is designed to help people understand their own biology, make small changes, and take more control over their health. Practicality : Clear.bio stresses simple, actionable guidance that can be applied in daily life rather than strict or overly complex diets. Unique Aspects Real-time glucose feedback : Clear.bio’s core differentiator is the use of a sensor and app to show how specific meals affect blood sugar in real time, turning nutrition into immediate, personalized feedback. Medical-device certification : In 2025, the company said it had obtained CE marking and registration as a Class I medical device under European MDR, supporting broader European expansion. Scalable smart guidance : The company introduced Smart Swap and Smart Signal to automate personalized advice and alerts, reducing reliance on manual dietitian work. Reimbursement in Dutch care paths : Clear.bio states that its treatment is reimbursed within certain Dutch diabetes care pathways, including ketenzorg diabetes in several cities and regions. Healthcare and scientific collaborations : The company highlights collaboration with the Diabetes Association Netherlands and with clinicians and researchers at institutions such as Amsterdam UMC and Radboud UMC.